Literature DB >> 18245391

Isolated cytochrome c oxidase deficiency as a cause of MELAS.

W Rossmanith1, M Freilinger, J Roka, T Raffelsberger, K Moser-Thier, D Prayer, G Bernert, R E Bittner.   

Abstract

BACKGROUND: MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) is one of the more common mitochondrial encephalomyopathies. About 80% of MELAS cases are caused by transition 3243A-->G in the mitochondrial tRNA(Leu(UUR)) gene (MT-TL1). Other mutations in MT-TL1, other mitochondrial tRNA genes and mitochondrial-encoded subunits of respiratory complex I account for the remainder of cases.
OBJECTIVE: To characterise the molecular basis of a MELAS case without a mutation in any recognised MELAS target gene. RESULTS AND METHODS: Deletion of a single nucleotide (7630delT) within MT-CO2, the gene of subunit II of cytochrome c oxidase (COX), was identified by mitochondrial DNA (mtDNA) sequencing. The deletion-induced frameshift results in a stop codon close to the 5' end of the reading frame. The lack of subunit II (COII) precludes the assembly of COX and leads to the degradation of unassembled subunits, even those not directly affected by the mutation. Despite mitochondrial proliferation and transcriptional upregulation of nuclear and mtDNA-encoded COX genes (including MT-CO2), a severe COX deficiency was found with all investigations of the muscle biopsy (histochemistry, biochemistry, immunoblotting).
CONCLUSIONS: The 7630delT mutation in MT-CO2 leads to a lack of COII with subsequent misassembly and degradation of respiratory complex IV despite transcriptional upregulation of its subunits. The causal association of the resulting isolated COX deficiency with MELAS is at odds with current concepts of the biochemical deficits underlying this common mitochondrial disease, and indicates that the genetic and pathobiochemical heterogeneity of MELAS is greater than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245391     DOI: 10.1136/jmg.2007.052076

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

Review 1.  Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.

Authors:  Susana Peralta; Alessandra Torraco; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

2.  Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile.

Authors:  Sara Roos; Kalliopi Sofou; Carola Hedberg-Oldfors; Gittan Kollberg; Ulrika Lindgren; Christer Thomsen; Mar Tulinius; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2018-10-12       Impact factor: 4.246

3.  Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.

Authors:  Tina Wenz; Francisca Diaz; Bruce M Spiegelman; Carlos T Moraes
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

4.  Identification of a Novel Variant in MT-CO3 Causing MELAS.

Authors:  Manting Xu; Robert Kopajtich; Matthias Elstner; Zhaoxia Wang; Zhimei Liu; Junling Wang; Holger Prokisch; Fang Fang
Journal:  Front Genet       Date:  2021-05-12       Impact factor: 4.599

5.  Upregulation of Mitochondrial Content in Cytochrome c Oxidase Deficient Fibroblasts.

Authors:  Aviram Kogot-Levin; Ann Saada; Gil Leibowitz; Devorah Soiferman; Liza Douiev; Itamar Raz; Sarah Weksler-Zangen
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

6.  Case report: a novel frameshift mutation in the mitochondrial cytochrome c oxidase II gene causing mitochondrial disorder.

Authors:  Laura Kytövuori; Mikko Kärppä; Hannu Tuominen; Johanna Uusimaa; Markku Saari; Reetta Hinttala; Kari Majamaa
Journal:  BMC Neurol       Date:  2017-05-18       Impact factor: 2.474

Review 7.  The molecular pathology of pathogenic mitochondrial tRNA variants.

Authors:  Uwe Richter; Robert McFarland; Robert W Taylor; Sarah J Pickett
Journal:  FEBS Lett       Date:  2021-02-12       Impact factor: 3.864

8.  A novel MT-CO2 variant causing cerebellar ataxia and neuropathy: The role of muscle biopsy in diagnosis and defining pathogenicity.

Authors:  Karen Baty; Maria E Farrugia; Sila Hopton; Gavin Falkous; Andrew M Schaefer; William Stewart; Hugh J Willison; Mary M Reilly; Emma L Blakely; Robert W Taylor; Yi Shiau Ng
Journal:  Neuromuscul Disord       Date:  2021-06-04       Impact factor: 4.296

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.